SmartIPL_NI System
Lumenis Be, Ltd. · Decision date Sep 19, 2026
What did the FDA decide?
The FDA record for K241973 covers the SmartIPL_NI System, submitted by Lumenis Be, Ltd. of Yokneam Ilit, Israel, and classified under the Powered Laser Surgical Instrument category, regulation number 878.4810, with primary product code GEX and subsequent codes ONF and QIU. The regulation medical specialty and review panel are both General and Plastic Surgery, and the submission is recorded as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan.
The agency recorded a decision of Substantially Equivalent (SESE) on 2026-09-19, with the application received on 07/05/2024. Under the 510(k) pathway this decision indicates the device was found substantially equivalent to a legally marketed predicate; it is a clearance, not a premarket approval. The record does not state which predicate device was cited, what components or modifications the submission described, or any indications, performance data or labeling terms, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 19, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K241973
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Lumenis Be, Ltd.
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Sep 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Applicant
- Lumenis Be, Ltd.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K241973 received
Application receipt date recorded by FDA.
K241973 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Lumenis Be, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yokneam Ilit
Sources and methodology
- Original FDA record: K241973
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


